A comparative analysis of the distribution of prosomatostatin-derived peptides in human and monkey neocortex
- PMID: 1672875
- DOI: 10.1002/cne.903030406
A comparative analysis of the distribution of prosomatostatin-derived peptides in human and monkey neocortex
Abstract
Comparative analyses were made of the immunohistochemical and biochemical distributions of three prosomatostatin-derived peptides (PSDP) in human, perfused monkey, and unperfused monkey neocortex. The PSDP we examined were the tetradecapeptide somatostatin 14 (SS14); the N-terminal extension of this peptide, somatostatin 28 (SS28); and somatostatin 28(1-12) (SS28(1-12)). In immunohistochemical experiments, numerous SS28-immunoreactive perikarya were located in both superficial and deep layers of perfused monkey cortex, but none were present in the cerebral cortex from unperfused monkey or autopsied human brains. In contrast, the number of SS28(1-12)-immunoreactive neurons was five times greater in the superficial cortical layers of unperfused monkey than of perfused monkey brain. Moreover, unperfused monkey and human cortex contained notably more SS14-immunoreactive processes than perfused monkey cortex. These data suggested that SS28 may have been converted into SS14 and SS28(1-12) in unperfused tissue during the post-mortem interval. This hypothesis was examined biochemically by measuring the levels of immunoreactivity of SS14, SS28, and SS28(1-12) in samples of unperfused monkey cortex frozen at different time intervals after removal from the brain. Samples frozen 10 minutes or longer after removal contained only 10-20% the level of SS28 immunoreactivity measured in samples frozen immediately or 1 minute after removal. The levels of SS14 and SS28(1-12) immunoreactivity did not demonstrate such reductions, and may instead have increased at early time points. To further characterize post-mortem effects on PSDP and to explore for species differences, we performed a detailed comparison of the regional, laminar, and cellular distribution of SS28(1-12) immunoreactivity under the three conditions. A progressive loss of immunoreactivity, particularly in radial fibers, was found at increasing post-mortem intervals in unperfused monkey neocortex, indicating that differences in density and distribution of immunoreactive fibers between human and perfused monkey may result from post-mortem peptide degradation in unperfused tissue. In contrast, the larger size of SS28(1-12)-immunoreactive white matter neurons in humans as compared to monkeys appeared partially due to a post-mortem effect but also reflected a species difference. In addition, the density of white matter neurons was found to be significantly greater in human than in perfused or unperfused monkey. These data indicate that any study of human autopsy material must be assessed in light of possible post-mortem effects.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
An immunohistochemical characterization of somatostatin-28 and somatostatin-281-12 in monkey prefrontal cortex.J Comp Neurol. 1986 Jun 1;248(1):1-18. doi: 10.1002/cne.902480102. J Comp Neurol. 1986. PMID: 2873154
-
Immunohistochemical and in situ hybridization analysis of the development of the rat somatostatin-containing neocortical neuronal system.J Comp Neurol. 1988 Mar 15;269(3):448-63. doi: 10.1002/cne.902690311. J Comp Neurol. 1988. PMID: 2897381
-
Regional heterogeneity in the distribution of somatostatin-28- and somatostatin-28(1-12)-immunoreactive profiles in monkey neocortex.J Neurosci. 1987 Apr;7(4):1133-44. doi: 10.1523/JNEUROSCI.07-04-01133.1987. J Neurosci. 1987. PMID: 2883266 Free PMC article.
-
Neuropeptides in Alzheimer's disease: a review and morphological results.Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):271-86. doi: 10.1016/0278-5846(86)90007-2. Prog Neuropsychopharmacol Biol Psychiatry. 1986. PMID: 2432629 Review.
-
Preclinical and clinical studies with somatostatin related to the central nervous system.Prog Neuropsychopharmacol Biol Psychiatry. 1990;14(4):473-502. doi: 10.1016/0278-5846(90)90003-y. Prog Neuropsychopharmacol Biol Psychiatry. 1990. PMID: 1978375 Review.
Cited by
-
Biological substrates underpinning diagnosis of major depression.Int J Neuropsychopharmacol. 2013 Sep;16(8):1893-909. doi: 10.1017/S1461145713000436. Epub 2013 May 14. Int J Neuropsychopharmacol. 2013. PMID: 23672886 Free PMC article. Review.
-
Dendritic-targeting GABA neurons in monkey prefrontal cortex: comparison of somatostatin- and calretinin-immunoreactive axon terminals.Synapse. 2008 Jun;62(6):456-65. doi: 10.1002/syn.20514. Synapse. 2008. PMID: 18361442 Free PMC article.
-
Reduced somatostatin in subgenual anterior cingulate cortex in major depression.Neurobiol Dis. 2011 Apr;42(1):116-24. doi: 10.1016/j.nbd.2011.01.014. Epub 2011 Jan 11. Neurobiol Dis. 2011. PMID: 21232602 Free PMC article.
-
Laminar-Specific Alterations in Calbindin-Positive Boutons in the Prefrontal Cortex of Subjects With Schizophrenia.Biol Psychiatry. 2023 Jul 15;94(2):142-152. doi: 10.1016/j.biopsych.2022.12.004. Epub 2022 Dec 8. Biol Psychiatry. 2023. PMID: 36868891 Free PMC article.
-
Expression of Transcripts Selective for GABA Neuron Subpopulations across the Cortical Visuospatial Working Memory Network in the Healthy State and Schizophrenia.Cereb Cortex. 2019 Jul 22;29(8):3540-3550. doi: 10.1093/cercor/bhy227. Cereb Cortex. 2019. PMID: 30247542 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources